Young women often delay looking into breast symptoms, research finds

by Dennis ThompsonYoung women who find a lump or other potential signs of breast cancer often delay for weeks before finally seeing a doctor, a new study shows.On average, young women waited two weeks

Updated on: April 28,2024 0

Young women often delay looking into breast symptoms, research finds

by Dennis ThompsonYoung women who find a lump or other potential signs of breast cancer often delay for weeks before finally seeing a doctor, a new study shows.On average, young women waited two weeks

Updated on:April 28,2024 0

A new screening protocol can detect aggressive prostate cancers more selectively

byTampere UniversityCredit: CC0 Public DomainProstate cancer is the most common cancer in men. As a cause of men's cancer death, it ranks the second in Finland and the third in Europe.A larg

Updated on: April 28,2024 0

A new screening protocol can detect aggressive prostate cancers more selectively

byTampere UniversityCredit: CC0 Public DomainProstate cancer is the most common cancer in men. As a cause of men's cancer death, it ranks the second in Finland and the third in Europe.A larg

Updated on:April 28,2024 0

New heated drug baths provide hope for patients with stomach cancer

by Megan Lakatos,Mayo ClinicCredit: Pixabay/CC0 Public DomainMayo Clinic researchers have used a new approach to chemotherapy to more than double the typical survival rate for patients with stom

Updated on: April 28,2024 0

New heated drug baths provide hope for patients with stomach cancer

by Megan Lakatos,Mayo ClinicCredit: Pixabay/CC0 Public DomainMayo Clinic researchers have used a new approach to chemotherapy to more than double the typical survival rate for patients with stom

Updated on:April 28,2024 0

Unlocking the body's hidden weapon against cancer: The role of broken chromosomes

by Zhejiang UniversityCredit: Pixabay/CC0 Public DomainScientists have unraveled the mechanisms of the cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes (c

Updated on: April 28,2024 0

Unlocking the body's hidden weapon against cancer: The role of broken chromosomes

by Zhejiang UniversityCredit: Pixabay/CC0 Public DomainScientists have unraveled the mechanisms of the cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes (c

Updated on:April 28,2024 0

Personalized cancer treatments based on testing drugs quickly leads to faster treatment, better outcomes

by Diana Azzam,The ConversationCredit: Pixabay/CC0 Public DomainDespite many efforts to find better, more effective ways to treat cancer, it remains aleading cause of death by disease&nbsp

Updated on: April 28,2024 0

Personalized cancer treatments based on testing drugs quickly leads to faster treatment, better outcomes

by Diana Azzam,The ConversationCredit: Pixabay/CC0 Public DomainDespite many efforts to find better, more effective ways to treat cancer, it remains aleading cause of death by disease&nbsp

Updated on:April 28,2024 0

FDA approves immunotherapy drug combo for non-muscle invasive bladder cancer

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainThe U.S. Food and Drug Administration (FDA) has approved the immunotherapy-boosting drug N-803, which is marketed under th

Updated on: April 28,2024 0

FDA approves immunotherapy drug combo for non-muscle invasive bladder cancer

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainThe U.S. Food and Drug Administration (FDA) has approved the immunotherapy-boosting drug N-803, which is marketed under th

Updated on:April 28,2024 0

Alecensa approved as first and only anaplastic lymphoma kinase inhibitor for non-small cell lung cancer

by Lori SolomonThe U.S. Food and Drug Administration has approved Genentech's Alecensa (alectinib) as adjuvant treatment following tumor resection in patients with anaplastic lymphoma kinase (ALK)

Updated on: April 28,2024 0

Alecensa approved as first and only anaplastic lymphoma kinase inhibitor for non-small cell lung cancer

by Lori SolomonThe U.S. Food and Drug Administration has approved Genentech's Alecensa (alectinib) as adjuvant treatment following tumor resection in patients with anaplastic lymphoma kinase (ALK)

Updated on:April 28,2024 0

AZD1390 with radiotherapy shows manageable safety profile and preliminary efficacy for patients with glioblastoma

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAZD1390, an ataxia telangiectasia mutant (ATM) kinase inhibitor, demonstrated a manageable safety profile in both recur

Updated on: April 28,2024 0

AZD1390 with radiotherapy shows manageable safety profile and preliminary efficacy for patients with glioblastoma

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAZD1390, an ataxia telangiectasia mutant (ATM) kinase inhibitor, demonstrated a manageable safety profile in both recur

Updated on:April 28,2024 0

AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

by Elana GotkineFor patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, ac

Updated on: April 28,2024 0

AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

by Elana GotkineFor patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, ac

Updated on:April 28,2024 0

Exploring the role of MIA-602 in overcoming doxorubicin-resistance in acute myeloid leukemia

by Impact Journals LLCEffect of treatment with MIA-602 on the growth of Doxorubicin-resistant K-562 tumors xenographed into nude mice. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.285

Updated on: April 28,2024 0

Exploring the role of MIA-602 in overcoming doxorubicin-resistance in acute myeloid leukemia

by Impact Journals LLCEffect of treatment with MIA-602 on the growth of Doxorubicin-resistant K-562 tumors xenographed into nude mice. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.285

Updated on:April 28,2024 0

AI-assisted breast-cancer screening may reduce unnecessary testing

byWashington University School of MedicineOn average, radiologists find one case of cancer (bottom images) in every 200 mammograms they evaluate. The top images show no cancer. In a recent study

Updated on: April 27,2024 0

AI-assisted breast-cancer screening may reduce unnecessary testing

byWashington University School of MedicineOn average, radiologists find one case of cancer (bottom images) in every 200 mammograms they evaluate. The top images show no cancer. In a recent study

Updated on:April 27,2024 0

Researchers identify new genetic risk factors for persistent HPV infections

byUniversity of Maryland School of MedicineDistribution of binding affinity IC50 values by HLA-DRB1 allele category (A) all binding predictions (B) Excluding non-binders (lC50 > 5000 nM). Cre

Updated on: April 27,2024 0

Researchers identify new genetic risk factors for persistent HPV infections

byUniversity of Maryland School of MedicineDistribution of binding affinity IC50 values by HLA-DRB1 allele category (A) all binding predictions (B) Excluding non-binders (lC50 > 5000 nM). Cre

Updated on:April 27,2024 0